EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Off‐the‐Shelf Synthetic Biodegradable Grafts Transform In Situ into a Living Arteriovenous Fistula in a Large Animal Model

Paul J Besseling iD, Wojciech Szymczyk, Martin Teraa iD, Raechel J Toorop, Dan Jing Wu iD, Rob C H Driessen, Arturo M Lichauco iD, Henk M Janssen, Melanie van de Kaa iD, Krista den Ouden, Petra M de Bree iD, Joost O Fledderus iD und 4 weitere

Advanced Healthcare Materials · 2024-07 · 13 (17)

DOI: 10.1002/adhm.202303888 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 26.03.2024. Verfasst von Paul J Besseling und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Hypertension, Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, 3584…. Hauptthemen laut MEDLINE: Goats, Blood Vessel Prosthesis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Kidney Foundation, Netherlands Organization for Scientific Research, Nierstichting.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current vascular access options require frequent interventions. In situ tissue engineering (TE) may overcome these limitations by combining the initial success of synthetic grafts with long‐term advantages of autologous vessels by using biodegradable grafts that transform into autologous vascular tissue at the site of implantation. Scaffolds (6 mm‐Ø) made of supramolecular polycarbonate‐bisurea (PC‐BU), with a polycaprolactone (PCL) anti‐kinking‐coil, are implanted between the carotid artery and jugular vein in goats. A subset is bio‐functionalized using bisurea‐modified‐Stromal cell‐derived factor‐1α (SDF1α) derived peptides and ePTFE grafts as controls. Grafts are explanted after 1 and 3 months, and evaluated for material degradation, tissue formation, compliance, and patency. At 3 months, the scaffold is resorbed and replaced by vascular neo‐tissue, including elastin, contractile markers, and endothelial lining. No dilations, ruptures, or aneurysms are observed and grafts are successfully cannulated at termination. SDF‐1α‐peptide‐biofunctionalization does not influence outcomes. Patency is lower in TE grafts (50%) compared to controls (100% patency), predominantly caused by intimal hyperplasia. Rapid remodeling of a synthetic, biodegradable vascular scaffold into a living, compliant arteriovenous fistula is demonstrated in a large animal model. Despite lower patency compared to ePTFE, transformation into autologous and compliant living tissue with self‐healing capacity may have long‐term advantages.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoatsBlood Vessel ProsthesisAnimalsTissue ScaffoldsAbsorbable ImplantsArteriovenous FistulaPolyestersCarotid ArteriesTissue EngineeringChemokine CXCL12Vascular Patency

Stichwörter der Autor:innen

AV shuntbiodegradable supramolecular materialbiofunctionalizationgoat modelin situ tissue engineeringvascular dialysis access

Substanzen

PolyestersChemokine CXCL12

Autor:innen und Institutionen

  • Department of Nephrology and Hypertension, Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht University, Utrecht, 3584 CX, the Netherlands.
  • Department of Vascular Surgery, University Medical Center Utrecht, Utrecht, 3584 CX, the Netherlands.
  • Department of Biomedical Engineering, and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, 5612 AZ, the Netherlands.
  • Mechanobiology Services Eindhoven, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, 5612 AZ, the Netherlands.
  • SyMO-Chem B.V, Eindhoven, 5612 AZ, the Netherlands.

ORCID-Profile: Paul J Besseling, Martin Teraa, Dan Jing Wu, Arturo M Lichauco, Melanie van de Kaa, Petra M de Bree, Joost O Fledderus, Carlijn V C Bouten, Gert J de Borst, Patricia Y W Dankers, Marianne C Verhaar

Förderung

  • Dutch Kidney Foundation
  • Netherlands Organization for Scientific Research
  • Nierstichting

Zitieren

APA

Besseling, P. J., Szymczyk, W., Teraa, M., Toorop, R. J., Wu, D. J., Driessen, R. C. H., Lichauco, A. M., Janssen, H. M., van de Kaa, M., den Ouden, K., de Bree, P. M., Fledderus, J. O., Bouten, C. V. C., de Borst, G. J., Dankers, P. Y. W., & Verhaar, M. C. (2024). Off‐the‐Shelf Synthetic Biodegradable Grafts Transform In Situ into a Living Arteriovenous Fistula in a Large Animal Model. Advanced Healthcare Materials, 13(17). https://doi.org/10.1002/adhm.202303888

Vancouver

Besseling PJ, Szymczyk W, Teraa M, Toorop RJ, Wu DJ, Driessen RCH, et al. Off‐the‐Shelf Synthetic Biodegradable Grafts Transform In Situ into a Living Arteriovenous Fistula in a Large Animal Model. Advanced Healthcare Materials. 2024;13(17). doi:10.1002/adhm.202303888

BibTeX
@article{Besseling2024,
  author = {Besseling, Paul J and Szymczyk, Wojciech and Teraa, Martin and Toorop, Raechel J and Wu, Dan Jing and Driessen, Rob C H and Lichauco, Arturo M and Janssen, Henk M and van de Kaa, Melanie and den Ouden, Krista and de Bree, Petra M and Fledderus, Joost O and Bouten, Carlijn V C and de Borst, Gert J and Dankers, Patricia Y W and Verhaar, Marianne C},
  title = {Off‐the‐Shelf Synthetic Biodegradable Grafts Transform In Situ into a Living Arteriovenous Fistula in a Large Animal Model},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {17},
  doi = {10.1002/adhm.202303888}
}
Kostenlos starten →